Benjamin A. Krantz
Impact in
- Ophthalmology top 2%
- Ocular Oncology and Treatments
-
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Cutaneous Melanoma Detection and Management
Papers in
- Oncology 6
- Pancreatic and Hepatic Oncology Research 4
- Lung Cancer Research Studies 1
- Peptidase Inhibition and Analysis 1
- Cancer Immunotherapy and Biomarkers 1
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Richard D. Carvajal (1 shared paper)Brian P. Marr (1 shared paper)Kimberly M. Komatsubara (1 shared paper)Nikita Dave (1 shared paper)Eileen M. O’Reilly (3 shared papers)Robert L. Fine (3 shared papers)Anthony P. Gulati (3 shared papers)Rebecca A. Moss (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Bioconjugate Chemistry (1 paper)Clinical Cancer Research (1 paper)Frontiers in Immunology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesFinlandIreland
In The Last Decade
Benjamin A. Krantz
9 papers receiving 507 citations
Peers
Comparison fields: 5 of 47
- Ophthalmology 203
- Oncology 196
- Neurology 101
- Epidemiology 176
- Cancer Research 33
Countries citing papers authored by Benjamin A. Krantz
This map shows the geographic impact of Benjamin A. Krantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin A. Krantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin A. Krantz more than expected).
Fields of papers citing papers by Benjamin A. Krantz
This network shows the impact of papers produced by Benjamin A. Krantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin A. Krantz. The network helps show where Benjamin A. Krantz may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin A. Krantz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 259 | |
| 2 | 2013 | 189 | |
| 3 | 2017 | 29 | |
| 4 | 2022 | 12 | |
| 5 | 2017 | 10 | |
| 6 | 2012 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2018 | 2 | |
| 9 | 2013 | 2 |
About Benjamin A. Krantz
Benjamin A. Krantz is a scholar working on Oncology, Epidemiology, Cancer Research, Surgery and Molecular Biology, having authored 9 papers that have together received 512 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Research Studies (1 paper), Retinal Development and Disorders (1 paper), Peptidase Inhibition and Analysis (1 paper), Neuroblastoma Research and Treatments (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Ophthalmology (203 citations), Oncology (196 citations), Neurology (101 citations), Epidemiology (176 citations) and Cancer Research (33 citations). Benjamin A. Krantz has collaborated with scholars based in United States, Finland and Ireland. Frequent co-authors include Richard D. Carvajal, Brian P. Marr, Kimberly M. Komatsubara, Nikita Dave, Eileen M. O’Reilly, Robert L. Fine, Anthony P. Gulati, Rebecca A. Moss, Stephen M. Schreibman and James A. Lee. Their work appears in journals such as Journal of Clinical Oncology, Bioconjugate Chemistry, Clinical Cancer Research, Frontiers in Immunology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.